Intratumoral dendritic cells and T cells predict survival in gastroenteropancreatic neuroendocrine neoplasms
Endocrine-Related Cancer · 2023
DOI: 10.1530/erc-22-0357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine-Related Cancer, 2023. Verfasst von Wiebke Werner und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatology and Gastroenterology, Charité Universitaetsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Gastrointestinal Neoplasms, Neuroendocrine Tumors, Carcinoma, Neuroendocrine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Clinical management of gastroenteropancreatic neuroendocrine neoplasms remains challenging. We recently introduced the FMS-like tyrosine kinase 3 ligand (FLT3LG) as a possible biomarker for a proinflammatory tumor microenvironment. Here, we put a spotlight on the quantitative assessment of classical dendritic cells (cDC) and T cells in the context of FLT3LG mRNA levels in a retrospective study on neuroendocrine tumor (NET) G2/G3 and neuroendocrine carcinoma (NEC) of pancreatic and gastric origin. The abundance of cDC and T cells and their relevant subpopulations were determined by immunofluorescent staining and correlated with FLT3LG mRNA levels as well as clinical outcomes. Immune cell counts attested to highly variable infiltration densities. Samples with the presence of cDC or high numbers of T cells exhibited increased FLT3LG expression. Abundance of cDC, defined as HLA-DR+CD11c+ cells with CLEC9a (cDC1) or CD1c (cDC2), as well as T cells correlated with FLT3LG mRNA levels and predicted disease-specific survival. Combining FLT3LG and T cell counts further improved this prediction. Therefore, tumor-infiltrating cDC and T cells are prognostic markers in NET G2/G3 or NEC and FLT3LG mRNA may serve as a simple-to-use biomarker for a quantitative estimate of their abundance, mandating prospective evaluation in the context of immune-targeted therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatology and Gastroenterology, Charité Universitaetsmedizin Berlin, Campus Virchow-Klinikum and Campus Charité Mitte, Berlin, Germany.
- Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine, University Düsseldorf, Düsseldorf, Germany.
ORCID-Profile: Frank Tacke, Linda Hammerich
Zitieren
APA
Werner, W., Detjen, K., Bruneau, A., Lurje, I., Nestel, N., Jann, H., Tacke, F., Wiedenmann, B., Roderburg, C., & Hammerich, L. (2023). Intratumoral dendritic cells and T cells predict survival in gastroenteropancreatic neuroendocrine neoplasms. Endocrine-Related Cancer. https://doi.org/10.1530/erc-22-0357
Vancouver
Werner W, Detjen K, Bruneau A, Lurje I, Nestel N, Jann H, et al. Intratumoral dendritic cells and T cells predict survival in gastroenteropancreatic neuroendocrine neoplasms. Endocrine-Related Cancer. 2023. doi:10.1530/erc-22-0357
BibTeX
@article{Werner2023,
author = {Werner, Wiebke and Detjen, Katharina and Bruneau, Alix and Lurje, Isabella and Nestel, Natalie and Jann, Henning and Tacke, Frank and Wiedenmann, Bertram and Roderburg, Christoph and Hammerich, Linda},
title = {Intratumoral dendritic cells and T cells predict survival in gastroenteropancreatic neuroendocrine neoplasms},
journal = {Endocrine-Related Cancer},
year = {2023},
doi = {10.1530/erc-22-0357}
}
EUVIMED